Newsroom

Industry News

16 Mar

Actinium to Present at the 22nd Annual Future Leaders in the Biotech Industry Conference March 20th in New York City

Actinium Pharmaceuticals, Inc. (NYSE MKT: ATNM)(“Actinium” or “the Company”), a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, today announced that the Company will present at the 22ndAnnual Future Leaders in the Biotech Industry Conference on Friday, March 20, 2015 at 11:00 a.m. The...

Read more

16 Mar

Inovio Pharmaceuticals and Academic Collaborators Receive $16 Million HIV Grant From National Institute of Allergy and Infectious Diseases

Inovio Pharmaceuticals, Inc. (INO) announced today that the company and its academic collaborators, including the University of Pennsylvania (UPenn), were awarded a new five-year $16 million Integrated Preclinical/Clinical AIDS Vaccine Development Program grant from the National Institute of Allergy and Infectious Diseases (NIAID). This five-year program grant was awarded...

Read more

16 Mar

Inovio Pharmaceuticals Reports 2014 Fourth Quarter and Year End Financial Results

DNA-Based Active Immunotherapy Achieves Industry Milestone With Clinically Relevant Efficacy Via T Cell Activation in Large Controlled Study Inovio Pharmaceuticals, Inc. (INO) today reported financial results for the fourth quarter and year ended December 31, 2014. Total revenue was $2.5 million and $10.5 million for the quarter and year...

Read more

16 Mar

Immunovaccine Announces Intent to Trade on OTCQX Marketplace in United States

Retains PCG Advisory to Build Wall Street Awareness HALIFAX, NOVA SCOTIA–(Marketwired – Mar 16, 2015) – Immunovaccine Inc. (“Immunovaccine” or “IMV”) (IMV.TO), a clinical stage vaccine and immunotherapy company, today announced that it is seeking approval to have its common shares trade on the OTCQX® Best Marketplace. The trading...

Read more

12 Mar

Athersys Reports Fourth Quarter and 2014 Annual Results

Management to Host Conference Call at 4:30pm EDT Today Athersys, Inc. (Nasdaq:ATHX) today announced its financial results for the fourth quarter and year ended December 31, 2014. “We have started off this year with some exciting news and look forward to reporting the initial results from our Phase 2...

Read more

12 Mar

Cynata Therapeutics Commences Further Stage of Stem Cell Manufacturing Program

Stem cell and regenerative medicine company Cynata Therapeutics Ltd (ASX: CYP) announced today that it had commenced a further stage of the current mesenchymal stem cell (MSC) manufacturing program with Waisman Biomanufacturing in Madison, Wisconsin. Dr Ross Macdonald, CEO and Managing Director stated, “Following the attainment of the major...

Read more

Page 221 of 274« First...102030...219220221222223...230240250...Last »

Enter your email address to receive notifications of new posts by email.

Latest Tweets

Follow

Follow this blog

Get every new post delivered right to your inbox.

Email address